Does Metformin Constipate You? Causes and Management Tips

Metformin is far more likely to cause diarrhea than constipation. Among the gastrointestinal side effects that make metformin infamous, constipation sits at the bottom of the list, with a pooled prevalence of roughly 1% in a large meta-analysis of observational studies. That said, the picture is more complicated than the clinical data suggest at first glance, and some people on metformin absolutely do experience constipation, sometimes for reasons that connect back to the drug in unexpected ways.

Where Constipation Ranks Among Metformin’s Gut Side Effects

Metformin’s reputation for upsetting the stomach is well earned, but the specific symptoms it triggers skew heavily toward the loose-stool end of the spectrum. A systematic review and meta-analysis of observational studies in people with type 2 diabetes found the following breakdown of gastrointestinal side effects: diarrhea at about 7%, bloating at around 6%, abdominal pain at roughly 5%, vomiting at about 2.4%, and constipation at just 1.1%.¹ In younger patients, the pattern is similar: a study of youth treated at a large referral center found that about 30% reported gastrointestinal symptoms overall, with abdominal pain and diarrhea being the most common complaints.²

So if you’ve started metformin and your main problem is constipation rather than diarrhea, you’re in the minority of people who experience gut trouble from this drug. That does not mean the metformin isn’t involved, but it does mean you and your doctor should look carefully at whether something else might be contributing.

Why Metformin Usually Pushes Things in the Other Direction

Understanding why constipation from metformin is uncommon requires a quick look at what the drug actually does in the gut. Metformin doesn’t just pass through the digestive tract on its way to lower blood sugar. It takes up residence in the intestinal lining at concentrations far higher than what circulates in the blood, and it actively changes how the gut works.

Several of those changes speed things up rather than slow them down. Metformin increases intestinal glucose uptake and lactate production, raises concentrations of a gut hormone called GLP-1, enlarges the bile acid pool in the intestine, and shifts the composition of gut bacteria.³ The GLP-1 increase is particularly relevant. Metformin stimulates GLP-1 release from tissue in the colon and ileum, and this effect depends on an energy-sensing enzyme called AMPK.⁴ GLP-1 slows gastric emptying but can also increase fluid secretion into the intestine, which promotes looser stools.

On top of that, research in animal models has shown that metformin interferes with the serotonin transporter in the gut. Serotonin is a major regulator of intestinal motility, and when its reuptake is blocked, more of it stays active in the gut wall, speeding up transit. One study found that metformin increased intestinal motility roughly fourfold and boosted water content in the large intestine by about 50%, effects that were reduced when a serotonin receptor blocker was introduced.⁵ These mechanisms help explain why diarrhea and loose stools dominate metformin’s side-effect profile, and why constipation is the odd one out.

The Gap Between What Patients Report and What Charts Record

Here’s where the story gets more interesting. While clinical records and provider assessments peg metformin-related constipation at around 1% or less, patient-reported surveys tell a different story. A post-hoc analysis comparing adverse event rates across multiple observational studies found that provider-oriented methods like medical record review captured constipation rates of just 0.6% to 1.0%. But when patients were asked directly through questionnaires, the constipation rate jumped to about 21%.⁶

That’s an enormous gap, and it shows up across other symptoms too: patient-reported abdominal pain and dyspepsia were both several times higher than what appeared in medical records. The discrepancy likely reflects a combination of factors. Patients may not mention constipation unless directly asked, doctors may not record symptoms they consider minor or unrelated to metformin, and the questionnaire format may capture intermittent symptoms that don’t rise to the level of a clinical complaint. Whatever the reason, it suggests that constipation during metformin therapy is more common than the headline clinical figures imply, even if it’s still less frequent than diarrhea.

When Constipation Happens on Metformin, What’s Behind It

If metformin’s dominant gut effects push toward diarrhea, what explains constipation in some users? Several possibilities overlap, and for most people, it’s not a single cause.

Diabetes itself: Type 2 diabetes can damage the nerves that control gut motility, a condition called diabetic autonomic neuropathy. When the nerves coordinating muscle contractions in the colon slow down, constipation follows. This is a common complication of long-standing diabetes and has nothing to do with metformin.
Other medications: Many people taking metformin also take calcium channel blockers for blood pressure, opioid-based pain medications, or iron supplements, all of which are well-known causes of constipation. The constipation gets noticed around the same time as metformin, but the culprit might be something else entirely.
Dietary and lifestyle shifts: A new diabetes diagnosis often comes with advice to change what you eat. Cutting back on fiber-rich foods (sometimes by accident, as people focus on carb-counting) or reducing physical activity during a period of feeling unwell can slow the gut down.
Individual gut microbiome variation: Metformin reshapes the bacterial populations in the intestine, and the direction of that reshaping varies between people. Some shifts may favor bacterial populations that produce less gas and fewer short-chain fatty acids, which could slow things down in certain individuals rather than speeding them up.

Research has confirmed that diabetic neuropathy and longer diabetes duration can diminish metformin’s effect on bowel frequency. A study examining defecation frequency found that neuropathy and disease duration were associated with reduced posttreatment stool frequency in metformin users, suggesting these conditions counteract metformin’s gut-stimulating effects.⁷ In other words, the same nerve damage that causes diabetic constipation may override the diarrhea-promoting effects of metformin, leaving constipation as the net result.

Does the Formulation or Dose Matter

Metformin comes in two main forms: immediate-release tablets (taken two or three times daily) and extended-release tablets (typically once daily). The extended-release version was developed partly to reduce gastrointestinal side effects by releasing the drug more slowly through the gut. In practice, the difference is smaller than many people expect. A systematic review and meta-analysis of nine randomized trials involving over 2,600 adults found that extended-release metformin reduced dyspepsia compared with immediate-release, but the two formulations had similar rates of other key gastrointestinal symptoms.⁸ Studies in younger patients have also found no significant difference in gastrointestinal symptom rates between standard and extended-release versions.²

As for dose, the relationship is less straightforward than you might assume. While it makes intuitive sense that higher doses would cause more gut trouble, one review of dosing strategies concluded that gastrointestinal side effects are “not generally dose related,” though transient dose reduction, slower dose increases over time, and taking the drug with meals can help.⁹ This means you shouldn’t automatically assume that cutting your dose will fix constipation (or diarrhea, for that matter), but taking metformin with food and titrating up slowly remain sound strategies for minimizing any gut complaints.

Who Is More Likely to Have Gut Problems

Sex appears to play a meaningful role. A systematic review and meta-analysis examining sex differences in metformin-related gastrointestinal side effects found that women had significantly higher odds of experiencing these problems compared with men, with roughly 85% higher odds overall.¹⁰ The finding held up in sensitivity analyses, suggesting it wasn’t a fluke of how particular studies were designed. The reasons aren’t entirely clear, but hormonal differences in gut motility, differences in body composition that affect drug concentrations, and higher rates of baseline functional gut disorders in women are all plausible contributors.

This is worth knowing if you’re a woman starting metformin and your doctor doesn’t mention the possibility of gut side effects. The evidence suggests you’re at higher risk than average and may benefit from a more cautious dose-escalation schedule.

Practical Steps for Managing Constipation While on Metformin

If you’re experiencing constipation and you’re taking metformin, the first step is figuring out whether metformin is actually the cause. Given that the drug much more commonly causes the opposite problem, it’s worth reviewing what else changed around the same time: new medications, dietary shifts, reduced activity, worsening blood sugar control (which can affect gut nerve function over time).

Regardless of the underlying cause, the management approach for constipation in people with diabetes follows a consistent ladder. Dietary and lifestyle changes should be the first step, including increasing fiber intake, drinking more water, and getting regular physical activity.¹¹ Some specific strategies that tend to help:

Soluble fiber first: Adding psyllium husk or ground flaxseed is generally better tolerated than jumping straight to wheat bran, which can cause bloating and cramping in people already dealing with metformin-related gut changes.
Timing your metformin with meals: Taking metformin in the middle of a substantial meal rather than on an empty stomach reduces peak drug concentrations in the gut and can ease side effects across the board.
Gradual dose titration: If you’ve recently started metformin or had a dose increase, ask your doctor about slowing down the schedule. Many of the gut side effects improve within the first few weeks as the body adjusts.
Hydration: Metformin can increase water content in the large intestine for some people, but if the overall effect in your case is constipation, inadequate fluid intake will make it worse. Aim for enough water that your urine stays a light straw color.
Over-the-counter osmotic laxatives: If dietary changes don’t resolve the problem, polyethylene glycol (the active ingredient in many store-brand laxatives) is generally safe for people with diabetes and can be used daily under a doctor’s guidance.

If constipation persists despite these measures, it’s worth asking about switching to the extended-release formulation if you’re not already on it. While the evidence for a broad advantage is mixed, individual responses vary, and some people do better with the slower drug release. Your doctor might also evaluate whether diabetic neuropathy is developing, since that could require its own treatment approach beyond just addressing the constipation symptom.

Vitamin B12 and the Long Game

One connection that rarely comes up in conversations about metformin and the gut is vitamin B12 deficiency. Long-term metformin use is a well-recognized cause of low B12 levels, and a growing body of evidence links this deficiency to the development and worsening of diabetic neuropathy.¹² Since neuropathy affecting the autonomic nerves is itself a major cause of constipation in people with diabetes, this creates a slow-motion feedback loop: metformin depletes B12, B12 deficiency worsens nerve damage, nerve damage slows the gut, and the patient develops constipation that gets attributed to something else entirely.

This doesn’t happen quickly. It typically takes years of metformin use for B12 levels to drop enough to cause neurological symptoms. But it’s one of the most underdiagnosed complications of metformin therapy, and periodic B12 monitoring is straightforward and inexpensive. If you’ve been on metformin for several years and constipation is a newer development, asking for a B12 level check is a reasonable move.

When Metformin Side Effects Get Misattributed

The flip side of the constipation question is also worth mentioning. Because metformin’s gut effects are so well known, there’s a tendency to blame the drug for any gastrointestinal symptom that shows up during treatment. One case report described a patient whose metformin-induced chronic diarrhea was misdiagnosed as irritable bowel syndrome for years, with the connection to metformin only recognized after multiple unnecessary workups.¹³ The misattribution runs both directions. Patients whose constipation stems from diabetic neuropathy, concurrent medications, or dietary changes sometimes blame metformin because it’s the most visible change in their routine, while patients with genuine metformin-related diarrhea sometimes get diagnosed with irritable bowel syndrome because nobody thinks to pause the drug and see what happens.

The practical lesson is that when a gut symptom develops while you’re on metformin, the most useful diagnostic step is often a supervised trial off the medication. If the symptom resolves within a few weeks, metformin was likely the culprit. If it doesn’t, the cause lies elsewhere. In the same youth study mentioned earlier, gastrointestinal symptoms increased from 13% to 33% when metformin was started and trended downward from 28% to 12% when it was stopped, confirming that the drug genuinely does cause gut symptoms in a meaningful number of people, but also that some symptoms persist regardless.²

The Serotonin Connection and Why It Matters Beyond Metformin

The finding that metformin works partly through the serotonin system in the gut has implications that go beyond explaining diarrhea. About 90% of the body’s serotonin is produced in the gastrointestinal tract, and serotonin plays a central role in regulating how quickly or slowly food moves through the intestines. Many common medications interact with this system. If you’re taking a selective serotonin reuptake inhibitor (SSRI) for depression or anxiety and you add metformin, both drugs are now affecting serotonin handling in the gut, potentially amplifying loose-stool effects. Conversely, if you’re taking a medication that slows serotonin signaling or gut motility (certain antihistamines, tricyclic antidepressants, or opioid pain medications), those drugs could counterbalance metformin’s pro-motility effects and tip the balance toward constipation.

This interaction hasn’t been studied extensively in humans yet, but the animal data showing that metformin’s gut effects can be blunted by serotonin receptor blockade suggest the interplay is real.⁵ If you’re on metformin plus other medications that affect serotonin or gut motility and you can’t figure out why your bowel habits have shifted in an unexpected direction, the combination may be more relevant than any single drug.